Product Information
SULFAMYLON 8.5% CREAM is a brand product labeled by Rising Pharma Holdings Inc., priced at $1.2343 per GM under NDC 16571072360. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application before 1982.
Strength
85 mg/g
Manufacturer
Rising Pharma Holdings Inc.NDC
16571072360
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
7/22/2026
Active Ingredients
MAFENIDE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA016763FDA Approved
Before 1982
On Market Since
5/18/2020
Pharmacological Classes
Price Statistics
The NADAC for SULFAMYLON 8.5% CREAM has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2343 per GM |
|---|---|
| All-time high | $1.2343 (Sep 30, 2026) |
| All-time low | $1.2141 (Nov 19, 2025) |
| 52-week high | $1.2343 |
| 52-week low | $1.2141 |
| Median price | $1.2239 |
| Average price | $1.2252 |
| Largest weekly change | +1.0% (Apr 22, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the mafenide acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
mafenide acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFAMYLON 8.5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for SULFAMYLON 8.5% CREAM, manufactured by Rising Pharma Holdings Inc., is $1.2343 per GM (NDC 16571072360), effective Sep 30, 2026.
How has the price of SULFAMYLON 8.5% CREAM changed over time?
Over the history we have for it, the NADAC for SULFAMYLON 8.5% CREAM has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SULFAMYLON 8.5% CREAM?
Since Apr 17, 2024, the NADAC for SULFAMYLON 8.5% CREAM has ranged from a low of $1.2141 (Nov 19, 2025) to a high of $1.2343 (Sep 30, 2026), with a median of $1.2239 per GM.
Are there cheaper alternatives to SULFAMYLON 8.5% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of SULFAMYLON 8.5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFAMYLON 8.5% CREAM?
SULFAMYLON 8.5% CREAM (NDC 16571072360) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a brand product.